The world of pharmaceuticals is a complex one, and for those of us who rely on medication, it can be a source of anxiety and confusion. For me, the recent change in the color of my pills has been a wake-up call, highlighting the potential dangers of these seemingly small changes. As I approach my 73rd year, I take six drugs daily, and the thought of accidentally taking the wrong pill or missing a dose is a terrifying prospect.
The issue of pill changes is not a new one, but it has become increasingly prevalent as the population ages. According to the source material, nearly 70% of Americans take at least one over-the-counter drug regularly, and the average adult takes two or more prescription drugs daily. This means that many of us are relying on medication to manage our health, and any changes to the pills we take could have serious consequences.
The main reason for these changes, as the article explains, is patent law. Generic drug manufacturers are required to change the appearance of their pills to distinguish them from the original brand-name medication. This can lead to confusion, especially for those who rely on the color, shape, and size of their pills to ensure they are taking the correct medication. A 2014 study found that a 34% likelihood of patients discontinuing their medication after the pill changed color, and a change in shape increased that likelihood to 66%.
The situation is further complicated by the fact that pharmacies often rotate among generic suppliers, each of which may put their own imprint on the pills. This means that even if a patient is taking the same medication, they may receive a different-looking pill each time they refill their prescription. As the author points out, this is a particular concern for older individuals, who may have failing eyesight or cognitive decline, and may not have anyone to help them scrutinize their medications.
The onus is on the individual patient to question the doctor, insurance company, pharmacist, or manufacturer about any changes to their medication. However, this is not always possible, especially for those who receive their drugs by mail and never have a meaningful conversation with their pharmacist. The author suggests that patients can take steps to mitigate the problem, such as ordering pill packs or blister packs, using online pill identifier tools, and asking doctors to write 'dispense as written' on prescriptions. But these solutions are not ideal, and the author argues that the onus should be on the pharmaceutical industry to regularize the size and shape of generic pills.
In my opinion, the issue of pill changes is a serious one that requires attention. The potential for confusion and serious health consequences is too great to ignore. As we age, our reliance on medication increases, and it is crucial that we can trust the pills we take. The pharmaceutical industry must take responsibility for ensuring that generic pills are consistent in appearance, and the FDA should issue guidance to drug manufacturers to regularize the size and shape of generic pills. Only then can we ensure that older individuals, in particular, are not at risk due to changes in the appearance of their medication.
In conclusion, the issue of pill changes is a complex one that requires a multi-faceted approach. While patients can take steps to mitigate the problem, the onus is ultimately on the pharmaceutical industry and regulatory bodies to ensure that generic pills are consistent and safe. As we age, our health and well-being depend on it.
